Literature DB >> 4285582

Development of resistance to antiviral drugs.

H E Renis, D A Buthala.   

Abstract

Mesh:

Substances:

Year:  1965        PMID: 4285582     DOI: 10.1111/j.1749-6632.1965.tb12568.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  11 in total

1.  Phosphonoacetic acid in the treatment of experimental ocular herpes simplex infections.

Authors:  R F Meyer; E D Varnell; H E Kaufman
Journal:  Antimicrob Agents Chemother       Date:  1976-02       Impact factor: 5.191

2.  Phosphonoacetic acid-resistant herpes simplex virus infection in hairless mice.

Authors:  R J Klein; A E Friedman-Kien
Journal:  Antimicrob Agents Chemother       Date:  1975-03       Impact factor: 5.191

3.  Phosphorylation of 5-bromodeoxycytidine in cells infected with herpes simplex virus.

Authors:  G M Cooper
Journal:  Proc Natl Acad Sci U S A       Date:  1973-12       Impact factor: 11.205

4.  Antiviral action of gliotoxin.

Authors:  J K McDougall
Journal:  Arch Gesamte Virusforsch       Date:  1969

5.  5-Iodo-2-deoxyuridine resistance of vaccinia viruses in cells endowed with thymidine kinase activity.

Authors:  M A Marcialis; E Biondi; A Atzeni; M L Schivo; P Uccheddu; B Loddo
Journal:  Experientia       Date:  1973-06-15

6.  Antiviral activity of arabinosylthymine in herpesviral replication: mechanism of action in vivo and in vitro.

Authors:  J F Aswell; G P Allen; A T Jamieson; D E Campbell; G A Gentry
Journal:  Antimicrob Agents Chemother       Date:  1977-08       Impact factor: 5.191

7.  Differential effect of arabinofuranosylthymine of the replication of human herpesviruses.

Authors:  R L Miller; J P Iltis; F Rapp
Journal:  J Virol       Date:  1977-09       Impact factor: 5.103

8.  Aminoadamantane-resistant strains of influenza A2 virus.

Authors:  J S Oxford; C W Potter
Journal:  J Hyg (Lond)       Date:  1973-06

9.  Sensitivity of Types 1 and 2 Herpes Simplex Virus to 5-Iodo-2'-Deoxyuridine and 9-beta-d-Arabinofuranosyladenine.

Authors:  D A Person; P J Sheridan; E C Herrmann
Journal:  Infect Immun       Date:  1970-12       Impact factor: 3.441

Review 10.  Antiviral therapy.

Authors:  H Stalder
Journal:  Yale J Biol Med       Date:  1977 Sep-Oct
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.